A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: Prospective studies are needed

Journal of Child and Adolescent Psychopharmacology

Volumn 17, Issue 4, 2007, Pages 503-509

  Barzman, Drew H ^b   DelBello, Melissa P ^a   Forrester, Jacob J ^a   Keck Jr , Paul E ^a   Strakowski, Stephen M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; OLANZAPINE; QUETIAPINE; VALPROIC ACID; ZIPRASIDONE;

ADOLESCENT; ADULT; AGITATION; ARTICLE; BEHAVIOR; CLINICAL EXAMINATION; CONFUSION; DEMOGRAPHY; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROCARDIOGRAPHY; EPISTAXIS; ETHNICITY; FEMALE; HOSPITAL PATIENT; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MYOSITIS; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROSPECTIVE STUDY; PSYCHIATRIC DEPARTMENT; PSYCHIATRIC DIAGNOSIS; RATING SCALE; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SEIZURE; SOMNOLENCE; TREATMENT RESPONSE;

EID: 34548687744     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.5124     Document Type: Article

References (14)

1. Aguilar EJ, Keshavan MS, Martnez-Quiles MD, Hernandez J, Gomez-Beneyto M, Schooler NR: Predictors of acute dystonia in first -episode psychotic patients. Am J Psychiatry 151:1819-1821, 1994.
2. th ed., Text Revision (DSM-IV-TR). Washington (D.C.), American Psychiatric Association, 2000
3. Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, Iwamoto T: Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: A double-blind, placebo-controlled comparison with intramuscular haloperidol. Psychopharmacology 188:281-292, 2006.
4. Blair J, Scahill L, State M, Martin A: Electrocardiographic changes in children and adolescents treated with ziprasidone: A prospective study. J Am Acad Child Adolesc Psychiatry 44:73-79, 2005.
5. Brook S, Lucey JV, Gunn KP: Intramuscular ziprasidone compared to intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group. J Clin Psychiatry 61:933-941, 2000.
6. Daniel DG, Potkin SG, Reeves KR, Swift RH, Harrigan EP: Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation with psychosis: A double-blind, randomized trial. Psychopharmacology 155:128-134, 2001.
7. Greene RW. The Explosive Child: A New Approach for Understanding and Parenting Easily Frustrated, "Chronically Inflexible" Children. New York, Harper-Collins Publishers, 1998.
8. Hazaray E, Ehret J, Posey DJ, Petti TA, McDougle CJ: Intramuscular ziprasidone for acute agitation in adolescents. J Child Adolesc Psychopharmacol 14:464-470, 2004.
9. Lesem MD, Zajecka JM, Swift RH, Reeves KR, Harrigan EP: Intramuscular ziprasidone, 2mg versus 10mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry 62:12-18, 2001.
10. Preskorn SH. Pharmacokinetics and therapeutics of acute intramuscular ziprasidone. Clin Pharmacokinet 44:1117-1133, 2005.
11. Staller JA: Intramuscular ziprasidone in youth: A retrospective chart review. J Child Adolesc Psychopharmacol 14:590-592, 2004.
12. Swift RH, Harrigan EP, Cappelleri JC, Kramer D, Chandler LP: Validation of the behavioural activity rating scale: A novel measure of activity in agitated patients. J Psychiatr Res 36:87-95, 2002.
13. Vitiello B, Hill JL, Elia J, Cunningham E, McLeer SV, Behar D: P.r.n. medications in child psychiatric patients: A pilot placebo-controlled study. J Clin Psychiatry 52:499-501, 1991.
14. Zimbroff, DL: Management of acute psychosis: From emergency to stabilization. CNS Spectr 11(Suppl 2):10-15, 2003.